243 related articles for article (PubMed ID: 24876734)
1. Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.
Inagaki Y; Gao J; Song P; Kokudo N; Nakata M; Tang W
World J Gastroenterol; 2014 May; 20(20):6123-32. PubMed ID: 24876734
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion.
Zhang K; Baeckström D; Brevinge H; Hansson GC
Tumour Biol; 1997; 18(3):175-87. PubMed ID: 9143414
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
[TBL] [Abstract][Full Text] [Related]
6. [Carbohydrate antigens in carcinoma invasion and metastasis].
Izumi Y; Kawamura YJ; Irimura T
Nihon Geka Gakkai Zasshi; 1996 Feb; 97(2):140-4. PubMed ID: 8632742
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.
Konno A; Hoshino Y; Terashima S; Motoki R; Kawaguchi T
Clin Exp Metastasis; 2002; 19(1):61-70. PubMed ID: 11918084
[TBL] [Abstract][Full Text] [Related]
8. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
[TBL] [Abstract][Full Text] [Related]
11. Associated expression of α2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer.
Fukasawa T; Asao T; Yamauchi H; Ide M; Tabe Y; Fujii T; Yamaguchi S; Tsutsumi S; Yazawa S; Kuwano H
Surg Today; 2013 Feb; 43(2):155-62. PubMed ID: 22398718
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
[TBL] [Abstract][Full Text] [Related]
14. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
Ho JJ; Siddiki B; Kim YS
Cancer Res; 1995 Aug; 55(16):3659-63. PubMed ID: 7627976
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
16. Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features.
Vierbuchen MJ; Fruechtnicht W; Brackrock S; Krause KT; Zienkiewicz TJ
Cancer; 1995 Sep; 76(5):727-35. PubMed ID: 8625173
[TBL] [Abstract][Full Text] [Related]
17. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
[TBL] [Abstract][Full Text] [Related]
18. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
19. [Ectopic expression of carbohydrate antigens that determine the metastatic potential of human colorectal carcinoma].
Irimura T
Gan To Kagaku Ryoho; 1993 Feb; 20(3):373-9. PubMed ID: 8094951
[TBL] [Abstract][Full Text] [Related]
20. Identification of the glycosidically bound sialic acid in mucin glycoproteins that reacts as "free sialic acid" in the Warren assay.
Bhavanandan VP; Ringler NJ; Gowda DC
Glycobiology; 1998 Nov; 8(11):1077-86. PubMed ID: 9751794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
